Attovia Therapeutics’ $105 Million Oversubscribed Series B Financing

Fenwick & West represented Attovia Therapeutics in the transaction.Attovia Therapeutics (“Attovia”), a developer of a pipeline of biotherapeutics with an initial focus on immune-mediated diseases, announced…